Capital Impact Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-59,577
| Closed | -$950K | – | 62 |
|
|
2024
Q1 | $950K | Hold |
59,577
| – | – | 1.23% | 30 |
|
|
2023
Q4 | $1M | Sell |
59,577
-7,490
| -11% | -$126K | 1.32% | 23 |
|
|
2023
Q3 | $784K | Buy |
67,067
+20,971
| +45% | +$245K | 1.31% | 25 |
|
|
2023
Q2 | $620K | Hold |
46,096
| – | – | 0.68% | 59 |
|
|
2023
Q1 | $764K | Buy |
46,096
+1,497
| +3% | +$24.8K | 0.94% | 27 |
|
|
2022
Q4 | $830K | Sell |
44,599
-14,702
| -25% | -$273K | 0.81% | 25 |
|
|
2022
Q3 | $907K | Sell |
59,301
-53,776
| -48% | -$822K | 0.9% | 16 |
|
|
2022
Q2 | $793K | Buy |
113,077
+13,755
| +14% | +$96.5K | 0.73% | 25 |
|
|
2022
Q1 | $823K | Buy |
+99,322
| New | +$823K | 0.6% | 65 |
|
|
2020
Q4 | – | Sell |
-203,133
| Closed | -$603K | – | 106 |
|
|
2020
Q3 | $603K | Hold |
203,133
| – | – | 0.18% | 107 |
|
|
2020
Q2 | $938K | Hold |
203,133
| – | – | 0.31% | 104 |
|
|
2020
Q1 | $782K | Buy |
203,133
+23,265
| +13% | +$89.6K | 0.33% | 100 |
|
|
2019
Q4 | $675K | Hold |
179,868
| – | – | 0.24% | 114 |
|
|
2019
Q3 | $948K | Buy |
+179,868
| New | +$948K | 0.36% | 114 |
|